The IBM Watson Health collapse (2015 launch through 2022 sale to Francisco Partners at approximately one-fifth of the initial investment) is the canonical enterprise AI failure case where the underlying technology was substantively functional and the organisational integration was not — physician rejection at named partner sites, workflow misalignment with clinical practice, and professional-identity-threat dynamics drove abandonment despite the underlying capability; the pattern reproduces at the cohort scale RAND Corporation's 2024 study (n=65 senior data scientists) identifies at the 80% AI-project failure rate, with organisational resistance dominant over technical limitation as the failure cause. The procurement-deck implication is that the change-management variable belongs in the discovery phase (AM-004) and the procurement decision (AM-140), not as a post-deployment afterthought.
Claim created at publish; review on 60-day cadence. Anchor sources: IBM Watson Health public reporting (Stat News, Wall Street Journal, IBM press releases on the 2022 sale to Francisco Partners); RAND Corporation 'The Root Causes of Failure for Artificial Intelligence Projects' RR-A2680-1 (2024, n=65); McKinsey 'The state of AI' research thread on change-management variable in deployment success; JPMorgan Chase public reporting on its 200,000-employee AI rollout and 450+ deployed use cases (Tearsheet, CIO Dive, Constellation Research). Sister claims: AM-010 (CIO playbook five operational characteristics; same JPMorgan + RAND anchors, different angle), AM-130 (four evidence classes for procurement readers; Watson as the structural-failure-mode anchor), AM-004 (discovery-phase organisational-readiness test), AM-140 (procurement-committee six pre-pilot questions including named owner accountability), AM-022 (change-management as the missing variable in deployment success). Trigger conditions to revisit before next cadence: (a) a subsequent named enterprise AI deployment failure at comparable scale where post-mortem reporting attributes failure primarily to technical limitation rather than organisational integration; (b) RAND or analogous research wave showing the failure cause distribution shifting toward technical limitation; (c) a major published methodology proposing that change-management work is properly downstream of deployment rather than upstream.
/holding/AM-011/Embed this claimiframe + oEmbed
The card auto-updates when the claim's status, last-reviewed date, or correction log changes. Embedders never need to refresh — the card is rendered live from the canonical record.
Email-me when AM-011's status, next review date, or correction log changes. One email per change. No newsletter subscription, no other mail.
The claim: The IBM Watson Health collapse (2015 launch through 2022 sale to Francisco Partners at approximately one-fifth of the initial investment) is the canonical enterprise AI failure case where the underlying technology was substantively functional and the organisational integration was not — physician rejection at named partner sites, workflow misalignment with clinical practice, and professional-identity-threat dynamics drove abandonment despite the underlying capability; the pattern reproduces at the cohort scale RAND Corporation's 2024 study (n=65 senior data scientists) identifies at the 80% AI-project failure rate, with organisational resistance dominant over technical limitation as the failure cause. The procurement-deck implication is that the change-management variable belongs in the discovery phase (AM-004) and the procurement decision (AM-140), not as a post-deployment afterthought.
About this register
The Reporting register tracks claims published from articles addressed to senior enterprise IT leaders — CIOs, IT directors, heads of platform. Claims are reviewed on a 30–90 day cadence; each review either reaffirms the claim, marks one substantive part as Partial, or marks it Not holding once the underlying evidence has been overtaken.
Recent corrections in Reporting
- AM-003 · Partial · 28 May 2026
Pricing/model drift: a $100/mo Pro tier now sits beside the $200 tier (added 9 Apr 2026) and the premium model is GPT-5.5 Pro. Core thesis holds; the single-$200-tier framing no longer matches. Re-verify current tiers at chatgpt.com/pricing.
- AM-002 · Not holding · 06 May 2026
URL state changed. The /the-agentic-ai-revolution-real-world-success-stories-and-strategic-insights-from-2024-2025/ slug now serves a deliberately rewritten retrospective (claimId AM-130, "Agentic AI 2024-2025 retrospective", published 04 May 2026) against audited primary sources. The 28 Apr 2026 redirect to /retractions/ has been lifted to allow that. AM-002 the claim remains Not holding — the original $3.50/dollar + 70% failure-rate framing was withdrawn and is not restored. AM-130 is a separate claim with its own evidence chain. Readers arriving at /holding/AM-002 see the withdrawal here; the article link surfaces the new piece at the URL the original lived at, with this entry as the audit trail.
- AM-121 · Holding · 2 May 2026
Klarna walk-back primary-source upgrade — added Siemiatkowski verbatim quotes via Bloomberg-cited-by-Fortune (9 May 2025) and the Uber-style freelance hiring detail via Entrepreneur. Closes the highest-priority evidence gap from the source dossier.
Reviews coming up in Reporting
- AM-020 · Holding · next +18d (18 Jun 2026)
The 40-60% TCO underestimate on enterprise agentic-AI deployments is not a cost-visibility failure — it is a cross-depa…
- AM-023 · Holding · next +18d (18 Jun 2026)
The 10 Apr 2026 Google AI Mode rollout to eight markets is the first vertical (restaurant booking) where agentic search…
- AM-013 · Holding · next +18d (18 Jun 2026)
Q1 2026 is the quarter enterprise agentic-AI crossed three thresholds simultaneously — the first at-scale in-the-wild e…